JP2007529485A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529485A5
JP2007529485A5 JP2007503402A JP2007503402A JP2007529485A5 JP 2007529485 A5 JP2007529485 A5 JP 2007529485A5 JP 2007503402 A JP2007503402 A JP 2007503402A JP 2007503402 A JP2007503402 A JP 2007503402A JP 2007529485 A5 JP2007529485 A5 JP 2007529485A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
formula
nitrogen
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007503402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529485A (ja
Filing date
Publication date
Priority claimed from GBGB0405933.3A external-priority patent/GB0405933D0/en
Application filed filed Critical
Publication of JP2007529485A publication Critical patent/JP2007529485A/ja
Publication of JP2007529485A5 publication Critical patent/JP2007529485A5/ja
Pending legal-status Critical Current

Links

JP2007503402A 2004-03-16 2005-03-15 ピラゾロ’3,4−b!ピリジン化合物、および4型ホスホジエステラーゼ(pde4)阻害剤としてのその使用 Pending JP2007529485A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0405933.3A GB0405933D0 (en) 2004-03-16 2004-03-16 Compounds
PCT/GB2005/000983 WO2005090348A1 (en) 2004-03-16 2005-03-15 Pyrazolo ’3,4-b! pyridine compounds, and their use as phosphodiesterase type 4 (pde4) inhibitors

Publications (2)

Publication Number Publication Date
JP2007529485A JP2007529485A (ja) 2007-10-25
JP2007529485A5 true JP2007529485A5 (https=) 2008-05-01

Family

ID=32117818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007503402A Pending JP2007529485A (ja) 2004-03-16 2005-03-15 ピラゾロ’3,4−b!ピリジン化合物、および4型ホスホジエステラーゼ(pde4)阻害剤としてのその使用

Country Status (5)

Country Link
US (1) US20080021058A1 (https=)
EP (1) EP1751151A1 (https=)
JP (1) JP2007529485A (https=)
GB (1) GB0405933D0 (https=)
WO (1) WO2005090348A1 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0230045D0 (en) 2002-12-23 2003-01-29 Glaxo Group Ltd Compounds
MXPA05007485A (es) 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
US20080275078A1 (en) 2004-03-16 2008-11-06 Glaxo Group Limited Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors
MX2008013411A (es) 2006-04-20 2008-11-04 Glaxo Group Ltd Nuevos compuestos.
CL2007001829A1 (es) 2006-06-23 2008-01-25 Smithkline Beecham Corp P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
GB0614570D0 (en) * 2006-07-21 2006-08-30 Glaxo Group Ltd Compounds
PL2046787T3 (pl) 2006-08-01 2011-10-31 Glaxo Group Ltd Związki pirazolo[3,4-b]pirydynowe i ich zastosowanie jako inhibitory PDE4
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
UY31636A1 (es) 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
AR070562A1 (es) 2008-02-06 2010-04-21 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
US8163743B2 (en) 2008-06-05 2012-04-24 GlaxoGroupLimited 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
WO2010016846A1 (en) * 2008-08-08 2010-02-11 Kalypsys, Inc. Heterocyclic modulators of tgr5 for treatment of disease
US8470835B2 (en) 2009-01-13 2013-06-25 Glaxo Group Limited Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase
JP5656880B2 (ja) 2009-03-09 2015-01-21 グラクソ グループ リミテッドGlaxo Group Limited Pi3キナーゼの阻害剤としての4−オキサジアゾール−2−イル−インダゾール
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
EP2408769A1 (en) 2009-03-17 2012-01-25 Glaxo Group Limited Pyrimidine derivatives used as itk inhibitors
LT2899191T (lt) 2009-04-30 2017-10-25 Glaxo Group Limited Oksazolo pakeistieji indazolai kaip pi3-kinazės inhibitoriai
JP2013512880A (ja) 2009-12-03 2013-04-18 グラクソ グループ リミテッド Pi3−キナーゼ阻害剤としてのインダゾール誘導体
WO2011067365A1 (en) 2009-12-03 2011-06-09 Glaxo Group Limited Benzpyrazole derivatives as inhibitors of p13 kinases
WO2011067364A1 (en) 2009-12-03 2011-06-09 Glaxo Group Limited Novel compounds
WO2011110575A1 (en) 2010-03-11 2011-09-15 Glaxo Group Limited Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
UY33373A (es) 2010-05-10 2011-12-30 Gilead Sciences Inc ?Compuestos de pirazolopiridina bifuncionales, su uso en terapia y composiciones que los comprenden?.
US9326987B2 (en) 2010-09-08 2016-05-03 Glaxo Group Limited Indazole derivatives for use in the treatment of influenza virus infection
RS54286B1 (sr) 2010-09-08 2016-02-29 Glaxosmithkline Intellectual Property Development Limited Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2(metiloksi)-3-piridinil]-metansulfonamida
WO2012035055A1 (en) 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
EP3323818A1 (en) 2010-09-22 2018-05-23 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
GB201018124D0 (en) 2010-10-27 2010-12-08 Glaxo Group Ltd Polymorphs and salts
WO2015055691A1 (en) 2013-10-17 2015-04-23 Glaxosmithkline Intellectual Property Development Limited Pi3k inhibitor for treatment of respiratory disease
RU2016112268A (ru) 2013-10-17 2017-11-22 Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Ингибитор PI3K для лечения респираторного заболевания
CN103819339A (zh) * 2014-03-25 2014-05-28 杜承贤 一种有机中间体丁酰基丙二酸二乙酯的制备方法
US20170100385A1 (en) 2014-05-12 2017-04-13 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions comprising danirixin for treating infectious diseases
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
GB201602527D0 (en) 2016-02-12 2016-03-30 Glaxosmithkline Ip Dev Ltd Chemical compounds
US20190161480A1 (en) 2016-08-08 2019-05-30 Glaxosmithkline Intellectual Property Development Limited Chemical Compounds
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
GB201706102D0 (en) 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
GB201712081D0 (en) 2017-07-27 2017-09-13 Glaxosmithkline Ip Dev Ltd Chemical compounds
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60201921T2 (de) * 2001-01-24 2005-10-06 Yung Shin Pharmaceutical Ind. Co., Ltd. Kondensierte Pyrazolverbindungen
GB0230045D0 (en) * 2002-12-23 2003-01-29 Glaxo Group Ltd Compounds
JP2006503108A (ja) * 2002-09-16 2006-01-26 グラクソ グループ リミテッド ピラゾロ[3,4−b]ピリジン化合物およびそれのホスホジエステラーゼ阻害薬としての使用

Similar Documents

Publication Publication Date Title
JP2007529485A5 (https=)
RU2006131304A (ru) Производные имидазо[1,2-c]пиримидинилуксусной кислоты
JP2024543976A5 (https=)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2020502103A5 (https=)
ATE442367T1 (de) Pyrazolo(3,4-b)pyridinverbindungen und ihre verwendung als phosphodiesterasinhibitoren
TW200630346A (en) Pyrimidines as prostaglandin D2 receptor antagonists
JP2019512535A5 (https=)
RU2018123779A (ru) Новые соединения
JP2005510473A5 (https=)
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
RU2015135967A (ru) ТЕТРАГИДРОИМИДАЗО[1,5-d][1,4]ОКСАЗЕПИНОВОЕ ПРОИЗВОДНОЕ
JP2013530179A (ja) 呼吸器合胞体ウイルス(rsv)感染の処置に使用するためのウレイド−ピラゾール誘導体
JP2006502183A5 (https=)
JP2012502067A5 (https=)
JP2012502017A5 (https=)
JP2014037426A5 (https=)
CA2648036A1 (en) Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
JP2023504415A5 (https=)
JP2011524896A5 (https=)
JP2006503845A5 (https=)
CA2624621A1 (en) Pyrazine derivatives
RU2012144543A (ru) Производные 3-(гетероариламино)-1,2,3,4-тетрагидро-9н-карбазола и их применение в качестве моддуляторов рецепторов простагландина d2
JP2022105013A (ja) ケモカインの生物活性を中和するためのピリミジノン誘導体およびその使用
JP2017519760A5 (https=)